LP-184 by Starlight Therapeutics for Melanoma: Likelihood of Approval

LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Melanoma.

Mirum expands rare disease portfolio with digestive disorder drugs – Pharmaceutical Technology

Mirum Therapeutics acquired two bile disorder drug products from Travere Therapeutics. Credit: peakSTOCK via Getty Images. California-based biotech Mirum Therapeutics has announced the completion of

September 6, 2023

Study identifies wildlife species likely involved in the origin of SARS-CoV-2

A new international study provides a shortlist of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic,

September 20, 2024

Ibex Launches Breast Cancer Biomarker Diagnostic Platform

What You Should Know: Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.